Press Releases July 14, 2026 05:43 PM

LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026

LeMaitre Vascular to Release Q2 2026 Earnings on August 4 with Conference Call Scheduled

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
LMAT

LeMaitre Vascular, Inc., a provider of vascular devices and implants, announced it will report its second quarter 2026 financial results after market close on August 4, 2026. The company will hold a conference call to discuss its earnings, business highlights, and outlook on the same day.

LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
LMAT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • LeMaitre Vascular specializes in devices and implants for peripheral vascular disease treatment.
  • The company will announce Q2 2026 earnings results on August 4, 2026, followed by a conference call.
  • Peripheral vascular disease affects over 200 million people globally, highlighting the market potential for LeMaitre's products.

BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com.

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.


Risks

  • Financial results might not meet market expectations, affecting stock performance.
  • Market demand for peripheral vascular devices could be influenced by healthcare regulation changes.
  • Competitive pressures in the medical device sector may impact LeMaitre's business growth.

More from Press Releases

20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity Aug 28, 2026 Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update Aug 28, 2026 AiRWA receives expected notification of deficiency from Nasdaq related to delayed filing of annual report on Form 10-K Aug 28, 2026 B2Gold Reports Fatality at the Masbate Gold Project Aug 28, 2026 Hudbay Files Early Warning Report for Panoro Minerals Ltd. Aug 28, 2026